Stocks on the move: M, TRNC, COTY >>> READ MORE


Recent Articles

The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak

VRX stock has rebounded off single-digit levels earlier this year, but the bull case for Valeant Pharmaceuticals remains flimsy. More 

9 Stocks That Have Paid Dividends for More Than a Century

Investors looking for income should consider the companies on this list, as these dividend stocks have been paying for more than a century. More 

Why Garmin Ltd. (GRMN) Stock Should Still Be Avoided

Garmin is a good company with some positives, but there aren't enough catalysts to justify buying GRMN stock ahead of earnings. More 

3 Stocks to Watch on Tuesday: Snap Inc (SNAP), Pfizer Inc. (PFE) and Texas Roadhouse Inc (TXRH)

The S&P 500 wants nothing to do with Snap (SNAP). Meanwhile, Pfizer (PFE) and Texas Roadhouse (TXRH) are headed north Tuesday on the back of Q2 earnings. More 

Pfizer Inc. (PFE) Stock Isn’t the Sexiest, But it’s Worth Checking Out

Pfizer has been doing good, but not great. Thanks to a low valuation and hefty dividend yield though, investors can buy PFE stock. More 

Gilead Sciences, Inc. (GILD) Stock Has Tremendous Potential Even Post-Rally

GILD stock fell long enough that its P/E is now under 8. This is value I can bank on, and this Gilead play can make you money too. More 

Amgen, Inc. (AMGN) Stock Is a Trade for Ailing Portfolios

Investors fear Amgen (AMGN) is a falling knife after dropping on earnings. Use that fear to sell puts for income in AMGN stock. More